Results 281 to 290 of about 177,876 (307)
Some of the next articles are maybe not open access.
Current Opinion in Ophthalmology, 2007
Giant cell arteritis is an important cause of blindness in patients over 60 years of age. We attempt to identify the important clinical aspects in the diagnosis and management of this disorder, so that treatment may be instituted expeditiously to limit visual loss.In addition, we identify current areas of standards in the investigation and treatment of
Peter J. Savino, Helen V Danesh-Meyer
openaire +6 more sources
Giant cell arteritis is an important cause of blindness in patients over 60 years of age. We attempt to identify the important clinical aspects in the diagnosis and management of this disorder, so that treatment may be instituted expeditiously to limit visual loss.In addition, we identify current areas of standards in the investigation and treatment of
Peter J. Savino, Helen V Danesh-Meyer
openaire +6 more sources
The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis.
Arthritis & Rheumatism, 2010Criteria for the classification of giant cell (temporal) arteritis were developed by comparing 214 patients who had this disease with 593 patients with other forms of vasculitis.
G. Hunder +29 more
semanticscholar +1 more source
Current Opinion in Rheumatology, 1990
Giant cell arteritis is a generalized inflammatory disorder involving large and medium-sized arteries. The etiology is unknown, although an autoimmune pathogenesis seems probable. In view of the clinical similarities between patients with positive biopsy findings for polymyalgia rheumatica and those with negative biopsy findings, many authors favor the
Claes Nordborg +2 more
openaire +3 more sources
Giant cell arteritis is a generalized inflammatory disorder involving large and medium-sized arteries. The etiology is unknown, although an autoimmune pathogenesis seems probable. In view of the clinical similarities between patients with positive biopsy findings for polymyalgia rheumatica and those with negative biopsy findings, many authors favor the
Claes Nordborg +2 more
openaire +3 more sources
The Lancet, 2014 In July 2013, a 64-year-old woman presented to her optometrist with a 4-day history of intermittent blurred vision in the left eye with a left-sided headache. The patient was unsure whether she had had jaw claudication or scalp tenderness. She had no previous ocular history except spectacles for hyperopia and presbyopia. She had been taking diclofenac,
Colm McAlinden +4 more
+8 more sources
Prevalence of Giant Cell Arteritis Relapse in Patients Treated With Glucocorticoids: A Meta‐Analysis
Arthritis care & research, 2020The relapse rate of patients with giant cell arteritis (GCA) treated with glucocorticoids (GCs) alone varied widely in observational series and randomized controlled trials (RCTs).
Sabine Mainbourg +10 more
semanticscholar +1 more source
Vision loss in giant cell arteritis
Practical Neurology, 2021Almost two-thirds of patients with giant cell arteritis (GCA) develop ocular symptoms and up to 30% suffer permanent visual loss. We review the three most common mechanisms for visual loss in GCA, describing the relevant ophthalmic arterial anatomy and ...
Laura Donaldson, Edward A. Margolin
semanticscholar +1 more source
Neurologic Clinics, 2019
"Giant cell arteritis (GCA) is a chronic, idiopathic, granulomatous vasculitis of medium and large arteries comprising overlapping phenotypes of cranial arteritis and extracranial GCA. Vascular complications are generally due to delay in diagnosis and initiation of effective treatment.
Karina Lazarewicz, Pippa Watson
openaire +6 more sources
"Giant cell arteritis (GCA) is a chronic, idiopathic, granulomatous vasculitis of medium and large arteries comprising overlapping phenotypes of cranial arteritis and extracranial GCA. Vascular complications are generally due to delay in diagnosis and initiation of effective treatment.
Karina Lazarewicz, Pippa Watson
openaire +6 more sources
Ustekinumab for the Treatment of Giant Cell Arteritis
Arthritis care & research, 2020To evaluate the efficacy and safety of ustekinumab (UST) in giant cell arteritis (GCA).
M. Matza +3 more
semanticscholar +1 more source
Rheumatic Disease Clinics of North America, 1995
Whereas giant cell arteritis (GCA) was considered a rare disease 50 years ago, the generalized arteritis is now recognized as an important and significant cause of morbidity in elderly people; its cause and pathogenesis is poorly understood. Glucocorticosteroids are the drug of choice in all clinical types of GCA.
Bo-Erik Malmvall +4 more
openaire +3 more sources
Whereas giant cell arteritis (GCA) was considered a rare disease 50 years ago, the generalized arteritis is now recognized as an important and significant cause of morbidity in elderly people; its cause and pathogenesis is poorly understood. Glucocorticosteroids are the drug of choice in all clinical types of GCA.
Bo-Erik Malmvall +4 more
openaire +3 more sources
The Journal of Emergency Medicine, 1986
Giant-cell or temporal arteritis is a generalized vasculitis that predominantly affects large- and medium-sized arteries in people over 50 years of age. The illness is commonly characterized by the initial symptoms of headache, temporal artery tenderness or pulselessness, musculoskeletal pain, fever, and fatigue.
Reginald K. Sherard, Samuel T. Coleridge
openaire +3 more sources
Giant-cell or temporal arteritis is a generalized vasculitis that predominantly affects large- and medium-sized arteries in people over 50 years of age. The illness is commonly characterized by the initial symptoms of headache, temporal artery tenderness or pulselessness, musculoskeletal pain, fever, and fatigue.
Reginald K. Sherard, Samuel T. Coleridge
openaire +3 more sources